Patients diagnosed at the study sites with rifampicinresistant research hub

Feasibility of the Application of a new Six-month Treatment for multidrug-resistant tuberculosis (MDR-TB) patients in France (FAST-MDR)

This study, called FAST-MDR, is looking at a new, shorter 6-month treatment for a severe type of tuberculosis (TB) that is hard to treat with usual medicines. It aims to see if this new treatment works as well as, or better than, older treatments for adults in France.